4.5 Interaction with other medicinal products and other forms of interaction  
 No interaction studies have been conducted with this medicinal product . 
 Clinical experience with pharmacologic use of other FVIIa -containing products indicates an elevated risk of thrombotic events when used simultaneously with activated prothrombin complex concentrates  (see section 4.4) . Based on a non- clinical study with eptacog alfa it is also not recommended to combine r 
 FVIIa and r 
 FXIII. There are no clinical data available on the interaction between r 
 FVIIa and r 
 FXIII.  
 
